Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02553161 · ClinicalTrials.gov registry record · NA
Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT02553161 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 214 participants.
The verdict
NCT02553161, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
A 16-week double blind, placebo-controlled investigation of escitalopram in adolescents with depression and/or anxiety with a family history of Bipolar Disorder. Subjects will be evaluated using semi-structured diagnostic interviews and symptom ratings, participate in a MRI scan and then randomized to treatment. Following randomization, high-risk youth will have visits every week for the first 4 weeks of treatment then biweekly up to 16 weeks during which time tolerability and ratings will be performed. MRI scan will be repeated at week 4.
Interventions
- DRUG Escitalopram
- BEHAVIORAL Cognitive behavioral Psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2015-12 |
| Est. Completion | 2022-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02553161
The ClinicalTrials.gov registry entry for NCT02553161 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Escitalopram is the first listed.
NCT02553161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02553161 about?
NCT02553161 is a clinical study titled "Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth". A 16-week double blind, placebo-controlled investigation of escitalopram in adolescents with depression and/or anxiety with a family history of Bipolar Disorder. Subjects will be evaluated using semi-structured diagnostic interviews and symptom ratings, participate in a MRI scan and then randomized ...
What is the current status of trial NCT02553161?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2015-12. Estimated completion is 2022-12.
What interventions are being tested in trial NCT02553161?
The interventions under investigation include: Escitalopram (DRUG), Cognitive behavioral Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02553161?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.